{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:50:43Z","timestamp":1789487443781,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2026R23"],"award-info":[{"award-number":["PNURSP2026R23"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05696-5","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:24:50Z","timestamp":1789482290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune-related hallmark pathway heterogeneity identifies a prognostic risk signature with independent external validation in glioblastoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Ahmed M.","family":"Abdelmaguid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M. A.","family":"Eltanany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal F.","family":"El-Khadragy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E. Abdel","family":"Moneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"Supplement3","key":"5696_CR1","first-page":"iii1","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018. Neurooncology. 2021;23(Supplement3):iii1\u2013105.","journal-title":"Neurooncology"},{"issue":"10","key":"5696_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"issue":"4","key":"5696_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2015.10.009","volume":"1","author":"D Hambardzumyan","year":"2015","unstructured":"Hambardzumyan D, Bergers G. Glioblastoma: defining tumor niches. Trends cancer. 2015;1(4):252\u201365.","journal-title":"Trends cancer"},{"issue":"4","key":"5696_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 2019;178(4):835\u201349. e21.","journal-title":"Cell"},{"issue":"1","key":"5696_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98\u2013110.","journal-title":"Cancer Cell"},{"issue":"6","key":"5696_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, et al. The molecular signatures database hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"1","key":"5696_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"7","key":"5696_CR8","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","volume":"181","author":"E Friebel","year":"2020","unstructured":"Friebel E, et al. Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes. Cell. 2020;181(7):1626\u201342. e20.","journal-title":"Cell"},{"issue":"1","key":"5696_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccell.2017.12.012","volume":"33","author":"Q Wang","year":"2018","unstructured":"Wang Q, et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. 2018;33(1):152.","journal-title":"Cancer Cell"},{"issue":"3","key":"5696_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Cancer Cell. 2017;31(3):326\u201341.","journal-title":"Cancer Cell"},{"issue":"2","key":"5696_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cct.2013.06.011","volume":"36","author":"J Subramanian","year":"2013","unstructured":"Subramanian J, Simon R. Overfitting in prediction models\u2013is it a problem only in high dimensions? Contemp Clin Trials. 2013;36(2):636\u201341.","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"5696_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5114\/wo.2014.47136","volume":"2015","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwi\u0144ska P, Wiznerowicz M. Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncology\/Wsp\u00f3\u0142czesna Onkologia. 2015;2015(1):68\u201377.","journal-title":"Contemp Oncology\/Wsp\u00f3\u0142czesna Onkologia"},{"issue":"6","key":"5696_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"5696_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, et al. Chinese Glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients. Genom Proteom Bioinform. 2021;19(1):1\u201312.","journal-title":"Genom Proteom Bioinform"},{"issue":"D1","key":"5696_CR15","doi-asserted-by":"publisher","first-page":"D561","DOI":"10.1093\/nar\/gks1114","volume":"41","author":"C Wu","year":"2013","unstructured":"Wu C, MacLeod I, Su AI. BioGPS and MyGene. info: organizing online, gene-centric information. Nucleic Acids Res. 2013;41(D1):D561\u20135.","journal-title":"Nucleic Acids Res"},{"key":"5696_CR16","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, et al. Scikit-learn: Machine learning in Python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"},{"issue":"1","key":"5696_CR17","doi-asserted-by":"publisher","first-page":"btac757","DOI":"10.1093\/bioinformatics\/btac757","volume":"39","author":"Z Fang","year":"2023","unstructured":"Fang Z, Liu X, Peltz G. GSEApy: a comprehensive package for performing gene set enrichment analysis in Python. Bioinformatics. 2023;39(1):btac757.","journal-title":"Bioinformatics"},{"issue":"40","key":"5696_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.21105\/joss.01317","volume":"4","author":"C Davidson-Pilon","year":"2019","unstructured":"Davidson-Pilon C. lifelines: survival analysis in Python. J Open Source Softw. 2019;4(40):1317.","journal-title":"J Open Source Softw"},{"issue":"4","key":"5696_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","volume":"24","author":"AR Pombo Antunes","year":"2021","unstructured":"Pombo Antunes AR, et al. Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nat Neurosci. 2021;24(4):595\u2013610.","journal-title":"Nat Neurosci"},{"issue":"3","key":"5696_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","volume":"24","author":"KP Bhat","year":"2013","unstructured":"Bhat KP, et al. Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma. Cancer Cell. 2013;24(3):331\u201346.","journal-title":"Cancer Cell"},{"issue":"1","key":"5696_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nrclinonc.2012.204","volume":"10","author":"S Tanaka","year":"2013","unstructured":"Tanaka S, et al. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat reviews Clin Oncol. 2013;10(1):14\u201326.","journal-title":"Nat reviews Clin Oncol"},{"issue":"1","key":"5696_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/jcmm.14760","volume":"24","author":"Q Lei","year":"2020","unstructured":"Lei Q, et al. TNIP1-mediated TNF\u2010\u03b1\/NF\u2010\u03baB signalling cascade sustains glioma cell proliferation. J Cell Mol Med. 2020;24(1):530\u20138.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"5696_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang Q, et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. 2017;32(1):42\u201356. e6.","journal-title":"Cancer Cell"},{"issue":"7","key":"5696_CR24","first-page":"887","volume":"19","author":"N Colwell","year":"2017","unstructured":"Colwell N, et al. Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neurooncology. 2017;19(7):887\u201396.","journal-title":"Neurooncology"},{"issue":"8","key":"5696_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1517\/13543780903052764","volume":"18","author":"C Adamson","year":"2009","unstructured":"Adamson C, et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs. 2009;18(8):1061\u201383.","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"5696_CR26","first-page":"815","volume":"116","author":"N Magnus","year":"2010","unstructured":"Magnus N, Garnier D, Rak J. Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells. Blood J Am Soc Hematol. 2010;116(5):815\u20138.","journal-title":"Blood J Am Soc Hematol"},{"key":"5696_CR27","doi-asserted-by":"publisher","first-page":"657472","DOI":"10.3389\/fcell.2021.657472","volume":"9","author":"H Zhu","year":"2021","unstructured":"Zhu H, et al. Targeting the complement pathway in malignant glioma microenvironments. Front Cell Dev Biology. 2021;9:657472.","journal-title":"Front Cell Dev Biology"},{"issue":"12","key":"5696_CR28","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1007\/s00405-025-09707-z","volume":"282","author":"DM Filippini","year":"2025","unstructured":"Filippini DM, et al. Challenges in pathological diagnosis of rare head and neck cancers: National survey and retrospective study. Eur Arch Otorhinolaryngol. 2025;282(12):6465\u201375.","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05696-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05696-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05696-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:28:22Z","timestamp":1789482502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05696-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5696"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05696-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with applicable research and publication guidelines. Ethical approval was not required because all transcriptomic and clinical datasets analyzed in this study were obtained from publicly available, de-identified databases. No human participants, animals, or personally identifiable information were directly involved in the present study.Not applicable. This study exclusively utilized publicly available de-identified datasets and did not involve the direct participation of human subjects","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient consent was waived because all transcriptomic and clinical datasets analyzed in the present study were obtained from publicly available databases and contained de-identified information.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical review and approval were waived for this study because all analyzed datasets were obtained from publicly available databases, including TCGA and CGGA, and no human participants or identifiable personal data were directly involved in the present study.","order":3,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1335"}}